Home > Insider Trading > Filing (0000904454-11-000319)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503685	Michele Ollier	C/O Index Ventures 2 Rue De Jargonnant Geneva, Switzerland V8 1207		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-06-29	877,723	$14.61	2,168,435	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

These securities are owned directly by Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware") and Index Ventures Parallel Entrepreneur Fund (Jersey), L.P. ("IVPEF"), of which Index Venture Associates III Ltd. is the general partner, and by Yucca Partners L.P. (Jersey Branch) as Administrator of the Index Co-Investment Scheme ("Yucca"). The Reporting Person, who is a Director of the Issuer, is a partner of Index Ventures, which is affiliated with the foregoing funds, however the Reporting Person disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein.
Such shares of Common Stock were sold in a registered secondary offering by the Issuer as follows: 314,515 shares by IVIII Jersey; 546,906 shares by IVIII Delaware; 10,281 shares by IVPEF; and 6,021 shares by Yucca.
IVIII Jersey is the direct beneficial owner of 569,571 shares of Common Stock; IVIII Delaware is the direct beneficial owner of 1,564,809 shares of Common Stock; IVPEF is the direct beneficial owner of 21,704 shares of Common Stock; and Yucca is the direct beneficial owner of 12,531 shares of Common Stock.